GATA3+CD3− cells were identified in proximity to IL-33+ CRC epithelial cells, suggesting that IL-33 released from these malignant cells may stimulate ILC2s in human CRC lesions (Fig. 4b). The gene discussed is IL33; the disease is colorectal carcinoma.